• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.

作者信息

Ameri A H, Mooradian M J, Emerick K S, Park J C, Wirth L J, Asgari M M, Tsao H, Lawrence D, Sullivan R J, Demehri S

机构信息

Center for Cancer Immunology and Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.

Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, U.S.A.

出版信息

Br J Dermatol. 2019 Nov;181(5):1095-1097. doi: 10.1111/bjd.18144. Epub 2019 Aug 7.

DOI:10.1111/bjd.18144
PMID:31102460
Abstract
摘要

相似文献

1
Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.着色性干皮病中皮肤鳞状细胞癌预防的免疫治疗策略。
Br J Dermatol. 2019 Nov;181(5):1095-1097. doi: 10.1111/bjd.18144. Epub 2019 Aug 7.
2
Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.一名着色性干皮病患者的转移性皮肤鳞状细胞癌对派姆单抗的快速反应：病例报告及文献复习
Eur J Cancer. 2017 Sep;83:99-102. doi: 10.1016/j.ejca.2017.06.022. Epub 2017 Jul 19.
3
Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma.帕博利珠单抗治疗一名着色性干皮病变异型及晚期皮肤鳞状细胞癌患者的疗效
Acta Oncol. 2022 Sep;61(9):1140-1142. doi: 10.1080/0284186X.2022.2109425. Epub 2022 Aug 11.
4
Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum.
J Am Acad Dermatol. 2001 Jun;44(6):1054. doi: 10.1067/mjd.2001.113476.
5
Xeroderma pigmentosum. Treatment with topically applied fluorouracil.
Arch Dermatol. 1968 Nov;98(5):526-7. doi: 10.1001/archderm.98.5.526.
6
Development of Merkel Cell Carcinoma and Squamous Cell Carcinoma During Treatment With Pembrolizumab for Metastatic Mucosal Melanoma.帕博利珠单抗治疗转移性黏膜黑色素瘤期间默克尔细胞癌和鳞状细胞癌的发生
Dermatol Surg. 2020 Nov;46(11):1443-1445. doi: 10.1097/DSS.0000000000002164.
7
Combination of targeted therapy and immune checkpoint blocker in a patient with xeroderma pigmentosum presenting an aggressive angiosarcoma and a recurrent non-resectable basal cell carcinoma.靶向治疗与免疫检查点阻断剂联合用于一名患有着色性干皮病且伴有侵袭性血管肉瘤和复发性不可切除基底细胞癌的患者。
Eur J Cancer. 2021 Jun;150:130-132. doi: 10.1016/j.ejca.2021.03.022. Epub 2021 Apr 23.
8
Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab.帕博利珠单抗（PD1抗体）使着色性干皮病中的黑色素瘤转移灶及多种非黑色素瘤皮肤癌消退。
Eur J Cancer. 2017 May;77:84-87. doi: 10.1016/j.ejca.2017.02.026. Epub 2017 Mar 31.
9
[Spinocellular carcinoma of the upper lip in a child with Xeroderma pigmentosum].[一名患有着色性干皮病的儿童的上唇棘细胞癌]
Pediatr Med Chir. 2009 May-Jun;31(3):126-9.
10
Chemoprevention of skin cancer in xeroderma pigmentosum.着色性干皮病中皮肤癌的化学预防
J Dermatol. 1992 Nov;19(11):715-8. doi: 10.1111/j.1346-8138.1992.tb03766.x.

引用本文的文献

1
The evolving treatment landscape for CSCC.皮肤鳞状细胞癌不断演变的治疗格局。
Arch Dermatol Res. 2025 Feb 26;317(1):502. doi: 10.1007/s00403-025-03933-5.
2
Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers.22例患有转移性或不可切除癌症的着色性干皮病患者使用免疫检查点抑制剂的疗效和不良事件的回顾性研究。
Front Oncol. 2023 Oct 25;13:1282823. doi: 10.3389/fonc.2023.1282823. eCollection 2023.
3
Can Cemiplimab Become a Life-Changer in Xeroderma Pigmentosum?
西米普利单抗能否成为色素性干皮病的改变命运之药？
Dermatol Pract Concept. 2023 Jul 1;13(3):e2023160. doi: 10.5826/dpc.1303a160.
4
Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review.着色性干皮病的免疫治疗：1例用西米普利单抗治疗的晚期皮肤鳞状细胞癌病例及文献综述
Oncotarget. 2021 May 25;12(11):1116-1121. doi: 10.18632/oncotarget.27966.